These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 101878)

  • 41. Three-dimensional structure-activity relationships.
    Marshall GR; Cramer RD
    Trends Pharmacol Sci; 1988 Aug; 9(8):285-9. PubMed ID: 3074545
    [No Abstract]   [Full Text] [Related]  

  • 42. Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine.
    Dunlap LE; Andrews AM; Olson DE
    ACS Chem Neurosci; 2018 Oct; 9(10):2408-2427. PubMed ID: 30001118
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The use of competitive ligand binding results in QSAR studies.
    Gómez-Jeria JS
    Farmaco Sci; 1985 May; 40(5):299-302. PubMed ID: 4007152
    [TBL] [Abstract][Full Text] [Related]  

  • 44. QSAR: a critical appraisal.
    Archer S
    NIDA Res Monogr; 1978; (22):86-102. PubMed ID: 30914
    [No Abstract]   [Full Text] [Related]  

  • 45. Quantitative structure-pharmacokinetics relationships and their importance in drug design, possibilities and limitations.
    Seydel JK
    Methods Find Exp Clin Pharmacol; 1984 Oct; 6(10):571-81. PubMed ID: 6513673
    [No Abstract]   [Full Text] [Related]  

  • 46. [Theoretical aspects of ascertaining parameters of action of biologically active compounds].
    Barth A; Franke R; Börnert D
    Pharmazie; 1976 Jun; 31(6):396-401. PubMed ID: 959301
    [No Abstract]   [Full Text] [Related]  

  • 47. Quantitative structure activity relationships of analgesics, narcotic antagonists, and hallucinogens: introduction.
    NIDA Res Monogr; 1978; (22):1-5. PubMed ID: 101878
    [No Abstract]   [Full Text] [Related]  

  • 48. [Analysis of the relation between pharmacokinetic processes and pharmacological effects in humans].
    Dorokhov VV; Kholodov LE
    Farmakol Toksikol; 1985; 48(5):119-25. PubMed ID: 3908140
    [No Abstract]   [Full Text] [Related]  

  • 49. Application of pharmaceutical profiling assays for optimization of drug-like properties.
    Di L; Kerns EH
    Curr Opin Drug Discov Devel; 2005 Jul; 8(4):495-504. PubMed ID: 16022186
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Early prediction of drug metabolism and toxicity: systems biology approach and modeling.
    Bugrim A; Nikolskaya T; Nikolsky Y
    Drug Discov Today; 2004 Feb; 9(3):127-35. PubMed ID: 14960390
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Principle of cooperation in the receptor function of the cytoplasmic membranes].
    Komissarov IV
    Farmakol Toksikol; 1977; 40(6):715-22. PubMed ID: 202484
    [No Abstract]   [Full Text] [Related]  

  • 52. [Advances in Hansch analysis].
    Guo ZR
    Yao Xue Xue Bao; 1983 Mar; 18(3):234-40. PubMed ID: 6349253
    [No Abstract]   [Full Text] [Related]  

  • 53. [Current problems in drug research. I. Determination of the quantitative structure-activity relationships of biosubstances: theoretical principles, accomplishments, assumptions and present state].
    Franke R; Oehme P
    Pharmazie; 1973 Aug; 28(8):489-508. PubMed ID: 4131698
    [No Abstract]   [Full Text] [Related]  

  • 54. [A new method for quantitative assessment of mechanisms of partitioning and absorption of drugs: linear solvation energy relationships].
    Li J; Sun J; He ZG
    Yao Xue Xue Bao; 2007 Jan; 42(1):13-8. PubMed ID: 17520801
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.